High-density lipoprotein mimetics: promises and challenges

被引:27
|
作者
Sviridov, Dmitri [1 ]
Remaley, Alan T. [2 ]
机构
[1] Baker IDI Heart & Diabet Inst, Lab Lipoprot & Atherosclerosis, Melbourne, Vic 3004, Australia
[2] NHLBI, Lipoprot Sect, NIH, Bethesda, MD 20892 USA
基金
英国医学研究理事会;
关键词
apolipoproteins; atherosclerosis; cholesterolmetabolism; lipoprotein metabolism; peptides; APOLIPOPROTEIN-A-I; REVERSE CHOLESTEROL TRANSPORT; PEPTIDE; 4F; ANTIINFLAMMATORY PROPERTIES; CORONARY ATHEROSCLEROSIS; REDUCES ATHEROSCLEROSIS; AMPHIPATHIC PEPTIDES; PLASMA-CLEARANCE; LESION FORMATION; OXIDIZED LIPIDS;
D O I
10.1042/BJ20150832
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The concept of lipoprotein mimetics was developed and extensively tested in the last three decades. Most lipoprotein mimetics were designed to recreate one or several functions of high-density lipoprotein (HDL) in the context of cardiovascular disease; however, the application of this approach is much broader. Lipoprotein mimetics should not just be seen as a set of compounds aimed at replenishing a deficiency or dysfunctionality of individual elements of lipoprotein metabolism but rather as a designer concept with remarkable flexibility and numerous applications in medicine and biology. In the present review, we discuss the fundamental design principles used to create lipoprotein mimetics, mechanisms of their action, medical indications and efficacy in animal models and human studies.
引用
收藏
页码:249 / 259
页数:11
相关论文
共 50 条
  • [31] Restoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high-density lipoprotein
    Bisoendial, RJ
    Hovingh, GK
    Levels, JHM
    Lerch, PG
    Andresen, I
    Hayden, MR
    Kastelein, JJP
    Stroes, ESG
    CIRCULATION, 2003, 107 (23) : 2944 - 2948
  • [32] HIGH-DENSITY LIPOPROTEIN PHOSPHOLIPIDS AND THEIR CORRELATION WITH HIGH-DENSITY LIPOPROTEIN CHOLESTEROL IN HEALTHY-YOUNG MEN
    CHRISTOPHE, A
    VERDONK, G
    ARCHIVES INTERNATIONALES DE PHYSIOLOGIE DE BIOCHIMIE ET DE BIOPHYSIQUE, 1980, 88 (05): : B265 - B266
  • [33] Lipoprotein(a) and High-Density Lipoprotein - A Tale of Two Cities?
    Maki, Kevin C.
    Duell, P. Barton
    JOURNAL OF CLINICAL LIPIDOLOGY, 2024, 18 (03) : e295 - e296
  • [34] High-density lipoprotein impedes glycation of low-density lipoprotein
    Younis, Nahla N.
    Soran, Handrean
    Charlton-Menys, Valentine
    Sharma, Reena
    Hama, Salam
    Pemberton, Philip
    Elseweidy, Mohamed M.
    Durrington, Paul N.
    DIABETES & VASCULAR DISEASE RESEARCH, 2013, 10 (02): : 152 - 160
  • [35] ULTRACENTRIFUGAL SUBFRACTIONATION OF HIGH-DENSITY LIPOPROTEIN
    SHEPHERD, J
    CAINE, EA
    BEDFORD, DK
    PACKARD, CJ
    ANALYST, 1984, 109 : 347 - 357
  • [36] The role of high-density lipoprotein in inflammation
    Navab, M
    Anantharamaiah, GM
    Fogelman, AM
    TRENDS IN CARDIOVASCULAR MEDICINE, 2005, 15 (04) : 158 - 161
  • [37] HIGH-DENSITY LIPOPROTEIN MODULATION TARGETS
    Mousa, S. S.
    Block, R. C.
    Mousa, S. A.
    DRUGS OF THE FUTURE, 2010, 35 (01) : 33 - 39
  • [38] HIGH-DENSITY LIPOPROTEIN METABOLISM IN MAN
    BLUM, CB
    LEVY, RI
    EISENBERG, S
    HALL, M
    GOEBEL, RH
    BERMAN, M
    JOURNAL OF CLINICAL INVESTIGATION, 1977, 60 (04): : 795 - 807
  • [39] SIGNIFICANCE OF HIGH-DENSITY LIPOPROTEIN CHOLESTEROL
    THOMPSON, P
    BORTZ, WM
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1978, 26 (10) : 440 - 442
  • [40] The Two Faces of High-Density Lipoprotein
    Van Linthout, Sophie
    CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (13) : 1443 - 1444